Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | 10 | $0 | $0 | 2013-07-09 |
| Santos Carlos | Sr. VP of Prod Dev/Reg Affairs | 9 | $0 | $0 | 2013-07-09 |
| Calder Douglas W | VP Strategic Plan/Cap Markets | 9 | $0 | $0 | 2013-07-09 |
| Bottjer Brian D | CFO and Controller | 8 | $0 | $0 | 2013-07-09 |
| OSMAN RONALD E | Director, 10% Owner | 18 | $0 | $0 | 2013-07-09 |
| Sitilides John | Director | 11 | $0 | $0 | 2013-07-09 |
| CHAPMAN CHRISTOPHER C | Director | 8 | $0 | $0 | 2013-07-09 |
| Scott Jeffrey | Director | 7 | $0 | $0 | 2013-07-09 |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | 10 | $0 | $0 | 2013-07-09 |
| KING EDMUND | Director | 3 | $0 | $0 | 2013-07-09 |
| MANNINO RAPHAEL J | Director | 7 | $0 | $0 | 2013-07-09 |
| PAPPAS PETER J | Director | 12 | $0 | $0 | 2013-07-09 |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRMAN | 18 | $0 | $0 | 2013-07-09 |
| ACCENTIA BIOPHARMACEUTICALS INC | 10% Owner | 11 | $0 | $0 | 2013-02-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 75,000 | — | $0 | 0 | SEC↗ |
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 150,000 | — | $0 | 0 | SEC↗ |
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 500,000 | — | $0 | 0 | SEC↗ |
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 45,000 | — | $0 | 0 | SEC↗ |
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 282,800 | — | $0 | 0 | SEC↗ |
| Bottjer Brian D | CFO and Controller | J Other deriv | 2013-07-09 | 2013-08-23 | 44,872 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 150,000 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 20,000 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 10,000 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 250,000 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 850,000 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 494,900 | — | $0 | 0 | SEC↗ |
| Calder Douglas W | FMR VP STRAT PLAN/CAP MARKET | J Other deriv | 2013-07-09 | 2013-08-23 | 386,048 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 20,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 20,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 100,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 919,100 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 1,251,869 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 500,000 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 1,500,000 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 3,000,000 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 250,000 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 150,000 | — | $0 | 0 | SEC↗ |
| DUFFEY SAMUEL S | FORMER CEO/PRESIDENT/GC | J Other deriv | 2013-07-09 | 2013-08-23 | 500,000 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 850,000 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 19,375 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 33,558 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 250,000 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 33,540 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 150,000 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 424,200 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 512,393 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| KING EDMUND | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| KING EDMUND | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 102,500 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 75,000 | — | $0 | 0 | SEC↗ |
| MANNINO RAPHAEL J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 75,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 281,250 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 414,545 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 459,550 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 40,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 75,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 1,000,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 125,000 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other deriv | 2013-07-09 | 2013-08-23 | 1,950,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 840,909 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 150,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 1,125,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 1,640,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 3,636,360 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 5,333,333 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 160,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 60,000 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 100,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 636,300 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 850,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 15,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 1,000 | — | $0 | 0 | SEC↗ |
| Santos Carlos | CHIEF EXECUTIVE OFFICER | J Other deriv | 2013-07-09 | 2013-08-23 | 494,124 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 107,500 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 105,000 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 105,000 | — | $0 | 0 | SEC↗ |
| Scott Jeffrey | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 65,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 30,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 90,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 90,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 200,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 105,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other deriv | 2013-07-09 | 2013-08-23 | 176,750 | — | $0 | 0 | SEC↗ |
| HIRSCHEL MARK D | CHIEF SCIENCE OFFICER | J Other | 2013-07-09 | 2013-08-23 | 55,800 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other | 2013-07-09 | 2013-08-23 | 18,306 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other | 2013-07-09 | 2013-08-23 | 84,951 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other | 2013-07-09 | 2013-08-23 | 111,610 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | FORMER DIRECTOR/EXEC. CHAIRM | J Other | 2013-07-09 | 2013-08-23 | 2,991 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other | 2013-07-09 | 2013-08-23 | 8,680,000 | — | $0 | 8,680,000 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other | 2013-07-09 | 2013-08-23 | 18,428 | — | $0 | 1,165,366 | SEC↗ |
| OSMAN RONALD E | Director, 10% Owner | J Other | 2013-07-09 | 2013-08-23 | 17,360,000 | — | $0 | 17,360,000 | SEC↗ |
| PAPPAS PETER J | Director | J Other | 2013-07-09 | 2013-08-23 | 524,545 | — | $0 | 0 | SEC↗ |
| PAPPAS PETER J | Director | J Other | 2013-07-09 | 2013-08-23 | 968,000 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | J Other | 2013-07-09 | 2013-08-23 | 27,927 | — | $0 | 0 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2013-02-22 | 2013-02-22 | 4,794,373 | $0.12 | $575.3K | 80,962,482 | SEC↗ |
| DUFFEY SAMUEL S | CEO/PRESIDENT/GENERAL COUNSE | A Award deriv | 2012-08-24 | 2012-09-14 | 1,251,869 | — | $0 | 1,251,869 | SEC↗ |
| Santos Carlos | Sr. VP of Prod Dev/Reg Affai | A Award deriv | 2012-08-24 | 2012-09-14 | 494,124 | — | $0 | 494,124 | SEC↗ |
| Calder Douglas W | VP Strategic Plan/Cap Market | A Award deriv | 2012-08-24 | 2012-09-14 | 386,048 | — | $0 | 386,048 | SEC↗ |
| Bottjer Brian D | Acting Chief Financial Offic | A Award deriv | 2012-08-24 | 2012-09-14 | 44,872 | — | $0 | 44,872 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-08-07 | 2012-08-31 | 400,000 | $0.75 | $300.0K | 85,881,349 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-08-07 | 2012-08-31 | 124,494 | $0.39 | $48.6K | 85,756,855 | SEC↗ |
| ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | J Other deriv | 2012-06-15 | 2012-06-15 | 125,000 | — | $0 | 414,545 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-05-31 | 2012-06-04 | 400,000 | $0.75 | $300.0K | 86,385,482 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-05-31 | 2012-06-04 | 104,133 | $0.42 | $43.7K | 86,281,349 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-04-27 | 2012-05-01 | 79,929 | $0.51 | $40.8K | 86,785,482 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-04-27 | 2012-05-01 | 400,000 | $0.75 | $300.0K | 86,865,411 | SEC↗ |
| DUFFEY SAMUEL S | CEO/PRESIDENT/GENERAL COUNSE | A Award deriv | 2012-03-30 | 2012-04-03 | 919,100 | — | $0 | 919,100 | SEC↗ |
| ODONNELL FRANCIS E JR | EXECUTIVE CHAIRMAN | A Award deriv | 2012-03-30 | 2012-04-03 | 459,550 | — | $0 | 459,550 | SEC↗ |
| Bottjer Brian D | Acting Chief Financial Offic | A Award deriv | 2012-03-30 | 2012-04-03 | 282,800 | — | $0 | 282,800 | SEC↗ |
| Sitilides John | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| OSMAN RONALD E | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| KING EDMUND | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| CHAPMAN CHRISTOPHER C | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| Scott Jeffrey | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| PAPPAS PETER J | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| MANNINO RAPHAEL J | Director | A Award deriv | 2012-03-30 | 2012-04-03 | 176,750 | — | $0 | 176,750 | SEC↗ |
| Santos Carlos | Sr. VP of Prod Dev/Reg Affai | A Award deriv | 2012-03-30 | 2012-04-03 | 636,300 | — | $0 | 636,300 | SEC↗ |
| Calder Douglas W | VP Strategic Plan/Cap Market | A Award deriv | 2012-03-30 | 2012-04-03 | 494,900 | — | $0 | 494,900 | SEC↗ |
| PAPPAS PETER J | Director | M Exercise deriv | 2012-03-21 | 2012-03-23 | 245,455 | $0.32 | $78.5K | 0 | SEC↗ |
| PAPPAS PETER J | Director | M Exercise deriv | 2012-03-21 | 2012-03-23 | 109,090 | $0.32 | $34.9K | 0 | SEC↗ |
| PAPPAS PETER J | Director | M Exercise | 2012-03-21 | 2012-03-23 | 245,455 | $0.32 | $78.5K | 1,492,545 | SEC↗ |
| PAPPAS PETER J | Director | M Exercise | 2012-03-21 | 2012-03-23 | 109,090 | $0.32 | $34.9K | 1,247,090 | SEC↗ |
| Sitilides John | Director | M Exercise deriv | 2012-03-16 | 2012-03-19 | 13,636 | — | $0 | 0 | SEC↗ |
| Sitilides John | Director | F Tax w/h | 2012-03-16 | 2012-03-19 | 7,273 | $0.60 | $4.4K | 27,927 | SEC↗ |
| Sitilides John | Director | M Exercise | 2012-03-16 | 2012-03-19 | 13,636 | $0.32 | $4.4K | 35,200 | SEC↗ |
| OSMAN RONALD E | Director | G Gift | 2012-03-15 | 2012-03-19 | 1,165,366 | — | $0 | 0 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-03-08 | 2012-03-09 | 57,242 | $0.58 | $33.2K | 87,265,411 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-03-08 | 2012-03-09 | 400,000 | $0.75 | $300.0K | 87,322,653 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-01-25 | 2012-03-09 | 400,000 | $0.75 | $300.0K | 87,811,152 | SEC↗ |
| ACCENTIA BIOPHARMACEUTICALS IN | 10% Owner | J Other | 2012-01-25 | 2012-03-09 | 88,499 | $0.34 | $30.1K | 87,722,653 | SEC↗ |
| OSMAN RONALD E | Director | M Exercise deriv | 2012-01-17 | 2012-01-19 | 116,705 | — | $0 | 0 | SEC↗ |
| ODONNELL FRANCIS E JR | Executive Chairman | M Exercise deriv | 2012-01-17 | 2012-01-19 | 590,909 | — | $0 | 0 | SEC↗ |
| OSMAN RONALD E | Director | F Tax w/h | 2012-01-17 | 2012-01-19 | 98,277 | $0.38 | $37.3K | 1,183,794 | SEC↗ |
| OSMAN RONALD E | Director | M Exercise | 2012-01-17 | 2012-01-19 | 116,705 | $0.32 | $37.3K | 1,282,071 | SEC↗ |
| ODONNELL FRANCIS E JR | Executive Chairman | M Exercise | 2012-01-17 | 2012-01-19 | 590,909 | $0.32 | $189.1K | 715,462 | SEC↗ |
| ODONNELL FRANCIS E JR | Executive Chairman | F Tax w/h | 2012-01-17 | 2012-01-19 | 497,604 | $0.38 | $189.1K | 217,858 | SEC↗ |